strengthenfda.org
FDA’s Appropriation for FY 19: Upsides and Downsides
In several recent columns, here, here, and here, I have explored the interplay between “Things are looking good for FDA in FY 19” and “Happy endings are not guaranteed.” On the one hand: the House…